Shen Zhuojian, Xu Xia, Lv Liangzhan, Dai Honglue, Chen Ju, Chen Baishen
Department of Thoracic Surgery, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
Lung Cancer Research Center of Sun Yat-Sen University, Sun Yat-Sen University, Guangzhou 510060, China.
Gastroenterol Res Pract. 2020 Oct 28;2020:6478653. doi: 10.1155/2020/6478653. eCollection 2020.
The migration and invasion of esophageal squamous cell carcinoma are associated with clinical outcomes, however, the mechanisms remain poorly understood. Here, we found that miR-21 is significantly overexpressed in ESCC, lung cancer, and bladder cancer compared with the adjacent normal tissue. MiR-21 and TPM1 expressions were analyzed by RT-qPCR and WB in 30 ESCC, 10 lung cancer, and 10 bladder cancer clinical specimens, each with matched adjacent normal tissue. Knockdown and overexpression of miR-21 as well as knockdown of TPM1 in ESCC cell lines were performed using synthetic oligonucleotides. TPM1 3'UTR luciferase reporter constructs were used to investigate targeting of TPM1 by miR-21. ESCC migration and invasion were assessed using transwell migration and invasion assays. Inhibition of miR-21 reduced migration and invasion in two ESCC cell lines, and overexpression of miR-21 promoted migration and invasion in vitro. Interestingly, TPM1 exhibited inverse patterns of expression compared with miR-21 in tissues and cell lines. Luciferase reporter assays demonstrated that TPM1 was directly regulated by miR-21. Moreover, the forced overexpression of miR-21 repressed the TPM1 expression, while silencing of miR-21 restored the TPM1 expression in ESCC cell lines. What is more, simultaneous silencing of miR-21 and TPM1 expressions did not alter the migratory and invasive characteristics demonstrating that the effects of miR-21 were mediated through TPM1. In conclusion, the aberrant overexpression of miR-21 is common in cancer and promotes the migration and invasion of ESCC through inhibiting the TPM1 expression. These results suggest that miR-21 may be a novel predictive marker and therapeutic target for treatment of ESCC.
食管鳞状细胞癌的迁移和侵袭与临床预后相关,然而,其机制仍知之甚少。在此,我们发现与相邻正常组织相比,miR-21在食管鳞状细胞癌、肺癌和膀胱癌中显著过表达。通过RT-qPCR和WB分析了30例食管鳞状细胞癌、10例肺癌和10例膀胱癌临床标本及其匹配的相邻正常组织中miR-21和TPM1的表达。使用合成寡核苷酸在食管鳞状细胞癌细胞系中进行miR-21的敲低和过表达以及TPM1的敲低。TPM1 3'UTR荧光素酶报告基因构建体用于研究miR-21对TPM1的靶向作用。使用Transwell迁移和侵袭试验评估食管鳞状细胞癌的迁移和侵袭。抑制miR-21可降低两种食管鳞状细胞癌细胞系的迁移和侵袭,而miR-21的过表达可促进体外迁移和侵袭。有趣的是,在组织和细胞系中,TPM1的表达模式与miR-21相反。荧光素酶报告基因试验表明TPM1受miR-21直接调控。此外,miR-21的强制过表达抑制了TPM1的表达,而miR-21的沉默恢复了食管鳞状细胞癌细胞系中TPM1的表达。更重要的是,同时沉默miR-21和TPM1的表达并未改变迁移和侵袭特性,表明miR-21的作用是通过TPM1介导的。总之,miR-21的异常过表达在癌症中很常见,并通过抑制TPM1的表达促进食管鳞状细胞癌的迁移和侵袭。这些结果表明,miR-21可能是治疗食管鳞状细胞癌的一种新型预测标志物和治疗靶点。